My first impression was that the page felt clean, simple, and easy to use
WEGOVY (semaglutide) prescribing information (Label 215256s024)
The FDA has issued public warnings about dosing errors and adverse events involving compounded semaglutide and tirzepatide - with more than 1,700 adverse events linked to compounded semaglutide and tirzepatide combined as of May 21, 2026, according to FDA's published adverse event data
J.MehtaN.SternW.ArbitE.ChristiansenC.et al (2010)
Rapid Uptake: It shows rapid uptake at the injection site
As may be expected, mean diabetes duration tended to be longer in patients receiving a greater number of background medications, ranging from 7.2 to 10.6 years in patients on metformin monotherapy to 8.4 to 17.3 years in patients receiving more than one background medication